Compare IOVA & CVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IOVA | CVE |
|---|---|---|
| Founded | 2007 | 2009 |
| Country | United States | Canada |
| Employees | N/A | 7211 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 50.4B |
| IPO Year | 2008 | N/A |
| Metric | IOVA | CVE |
|---|---|---|
| Price | $3.82 | $25.43 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 2 |
| Target Price | $9.00 | ★ $30.50 |
| AVG Volume (30 Days) | ★ 12.9M | 12.8M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 2.27% |
| EPS Growth | ★ 14.84 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $51.55 | N/A |
| Revenue Next Year | $37.55 | $1.83 |
| P/E Ratio | ★ N/A | $18.07 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.64 | $11.60 |
| 52 Week High | $5.63 | $27.65 |
| Indicator | IOVA | CVE |
|---|---|---|
| Relative Strength Index (RSI) | 52.85 | 52.39 |
| Support Level | $2.02 | $24.69 |
| Resistance Level | $4.34 | $27.65 |
| Average True Range (ATR) | 0.30 | 0.86 |
| MACD | 0.01 | -0.24 |
| Stochastic Oscillator | 52.58 | 23.99 |
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.
Cenovus Energy Inc is a Canadian integrated energy group. The group's upstream operations include oil sands projects in northern Alberta; thermal and conventional crude oil, natural gas, and natural gas liquids (NGLs) projects across Western Canada; crude oil production offshore Newfoundland and Labrador; and natural gas and NGLs production offshore China and Indonesia. Its downstream operations include upgrading and refining operations in Canada and the U.S., and commercial fuel operations across Canada. The group's reportable segments are: Oil Sands, Conventional, Offshore, Canadian Refining, U.S Refining, and Corporate and Eliminations. Maximum revenue is generated from its Oil Sands segment. Geographically, the group derives maximum revenue from the U.S., followed by Canada and China.